GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,769
Funds Holding Change
+16
Funds Holding Growth
+0.6%
Value
$495B
Holding in Top 10
448
Top 10 Change
+40
Top 10 Growth
+10%
Value Growth
+7%
New
151
Increased
1,185
Reduced
1,250
Closed
98
Capital Inflow
$58B
Capital Outflow
$18.1B
Net Capital Flow
+$39.9B
Capital Flow Change
+$43.9B
Calls
$5.62B
Puts
$7.6B
Net Calls
-$1.98B
Put/Call Ratio
1.35